SIREN : 499224301
HOLDING PHARMASUD ACTIVITES is a French company founded 18 years ago, specialized in the sector Activités des sièges sociaux. Based in NARBONNE (11100), this company of category PME shows in 2018 a revenue of 4.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | 4 413 289 € | 4 192 662 € | 4 034 393 € |
| Net income | 125 728 € | -50 076 € | -5 278 € | -3 222 € | -8 774 € | 99 759 € | 134 040 € | 104 757 € |
| EBITDA | -5 448 € | -25 110 € | -5 278 € | -4 968 € | -8 738 € | 245 292 € | 285 325 € | 244 125 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | 2.3% | 3.2% | 2.6% |
In 2024, HOLDING PHARMASUD ACTIVITES generates positive net income of 126 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 105 k€ -> 126 k€.
-5 448 €
-5 448 €
125 728 €
The debt ratio (= Financial debt / Equity x 100) stands at 135%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 11.3 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.
135.327%
42.134%
11.274
In 2024, the debt ratio of HOLDING PHARMASUD ACTIVITES (135.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of HOLDING PHARMASUD ACTIVITES (42.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of HOLDING PHARMASUD ACTIVITES (11.27) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 66.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
66.846
-890.492
In 2024, the liquidity ratio of HOLDING PHARMASUD ACTIVITES (66.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of HOLDING PHARMASUD ACTIVITES (-890.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 51 days. Excellent situation: suppliers finance 51 days of the operating cycle (retail model).
0 €
0 j
51 j
0 j
Based on 103 transactions of similar company sales in 2024, the value of HOLDING PHARMASUD ACTIVITES is estimated at 1 195 411 € (range 410 460€ - 3 218 869€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HOLDING PHARMASUD ACTIVITES with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of HOLDING PHARMASUD ACTIVITES in 2018 is 4.4 M€.
Yes, HOLDING PHARMASUD ACTIVITES generated a net profit of 126 k€ in 2024.
The headquarters of HOLDING PHARMASUD ACTIVITES is located in NARBONNE (11100), in the department Aude.
The tax return of HOLDING PHARMASUD ACTIVITES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HOLDING PHARMASUD ACTIVITES operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.